Free Trial

Addus HomeCare (ADUS) Stock Forecast & Price Target

$118.82
-0.40 (-0.34%)
(As of 07/19/2024 ET)

Addus HomeCare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 9 Wall Street analysts who have issued ratings for Addus HomeCare in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 1 has given a sell rating, and 8 have given a buy rating for ADUS.

Consensus Price Target

$116.25
-2.16% Downside
High Forecast$136.00
Average Forecast$116.25
Low Forecast$83.00

According to the 9 analysts' twelve-month price targets for Addus HomeCare, the average price target is $116.25. The highest price target for ADUS is $136.00, while the lowest price target for ADUS is $83.00. The average price target represents a forecasted downside of -2.16% from the current price of $118.82.

TypeCurrent Forecast
7/22/23 to 7/21/24
1 Month Ago
6/22/23 to 6/21/24
3 Months Ago
4/23/23 to 4/22/24
1 Year Ago
7/22/22 to 7/22/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$116.25$113.43$103.83$116.67
Forecasted Upside-2.16% Downside9.64% Upside11.73% Upside20.10% Upside
Get Addus HomeCare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

ADUS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ADUS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Addus HomeCare Stock vs. The Competition

TypeAddus HomeCareMedical CompaniesS&P 500
Consensus Rating Score
2.78
2.72
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-2.16% Downside3,282.89% Upside10.04% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/28/2024Macquarie
2 of 5 stars
 Initiated CoverageOutperform$136.00+19.08%
6/18/2024TD Cowen
4 of 5 stars
 Boost TargetBuy ➝ Buy$119.00 ➝ $128.00+7.93%
6/7/2024Oppenheimer
3 of 5 stars
 Boost TargetOutperform ➝ Outperform$118.00 ➝ $130.00+12.00%
5/31/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$120.00 ➝ $128.00+13.27%
5/7/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$115.00 ➝ $118.00+20.54%
4/23/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight$83.00-11.22%
2/29/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$102.00+10.62%
2/5/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
8/2/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$100.00 ➝ $105.00+12.98%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 01:08 AM ET.

ADUS Forecast - Frequently Asked Questions

What is Addus HomeCare's forecast for 2024?

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Addus HomeCare is $116.25, with a high forecast of $136.00 and a low forecast of $83.00.

Should I buy or sell Addus HomeCare stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last year. There is currently 1 sell rating and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ADUS shares.

Does Addus HomeCare's stock price have much upside?

According to analysts, Addus HomeCare's stock has a predicted upside of 10.93% based on their 12-month stock forecasts.

Has Addus HomeCare been downgraded by Wall Street analysts recently?

Over the previous 90 days, Addus HomeCare's stock had 1 downgrade by analysts.

What analysts cover Addus HomeCare?

Addus HomeCare has been rated by research analysts at Bank of America, Barclays, Macquarie, Oppenheimer, Stephens, and TD Cowen in the past 90 days.

Do Wall Street analysts like Addus HomeCare more than its competitors?

Analysts like Addus HomeCare more than other "medical" companies. The consensus rating score for Addus HomeCare is 2.78 while the average consensus rating score for "medical" companies is 2.72. Learn more on how ADUS compares to other companies.


This page (NASDAQ:ADUS) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners